- First biomedical machine learning framework BioSymetrics introduces a new component that enables users to reduce bias, increase speed to market and improve patient outcomes.
- Augusta Architect enables data scientists in hospitals, healthcare systems, and pharmaceutical companies to perform fast, effective data pre-processing and ML.
- New component has a simple syntax that allows users to quickly process and integrate multiple, diverse datatypes and run or compare multiple ML
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Parkland Hospital Saves $17M With AI-Powered Predictive Model to Prevent In-Hospital Adverse Drug Events
- Parkland Hospital delivers over $17M in savings preventing in-hospital adverse drug events using an AI-powered predictive model developed by the Park Center for Clinical Innovation (PCCI).- The program, Patients at Risk for Adverse Drug Events (PARADE) demonstrated positive results combating ADEs, a problem that impacts more than 450,000 patients nationwide and increases the risk for re-admissions lengthen the stay of patients by 2 to 3 days and adds almost $4B in extra hospital costs
Read More
Q&A: How the VHA’s Innovator’s Network Is Transforming Veteran Care
Dr. Ryan Vega explains how the VHA’s Innovator’s Network (iNET) is transforming how the VA identifies, incubates, and deliver healthcare innovation to improve healthcare for veterans.
Innovation is the bud from which all things radical seem to bloom. It’s also the critical element at the center of the Veterans Health Administration (VHA) objectives to improve the quality and reach of healthcare for its veterans. Changes spurred by the Mission Act—which hopes to create greater access through
Read More
InsightRX Lands $10M for Precision Medicine Dosing at the Point of Care Platform
- InsightRX raises $10M led by HealthX Ventures to accelerate the adoption of its precision dosing at the point of care platform.
- The platform leverages patient-specific data, pharmacology models, and machine learning to understand each patient’s unique pharmacological profile to guide treatment decisions.
- InsightRX plans to use the new funding to deepen its integration capabilities, broaden development across additional therapeutic areas, and continue its expansion into health
Read More
4 Steps Healthcare Organizations Need to Take to Automate Their Data
According to IDC, all the data that’s being created and captured in healthcare is projected to grow by 36 percent (CAGR)—more than any other industry.
While managing growing volumes of data is a common challenge for many organizations across all sectors, healthcare is uniquely set apart by the sheer number of new data sources that’s being made available—with new sources being added all the time. This is driven in large part by advancements in telemedicine, personalized or precision medicine, as
Read More
Report: Precision Medicine Is Impossible Without AI and Machine Learning
Artificial intelligence (AI) and machine learning are driving a great deal of the healthcare innovation in precision medicine, according to a new Chilmark Research report. The report reveals achieving the full potential of precision medicine is impossible to realize without applying AI and machine learning. Specifically, leveraging advanced machine learning and deep learning technology can rapidly analyze large datasets that outperform clinicians and researchers. Precision Medicine: Making
Read More
UIUC, Infosys Form Strategic Partnership to Develop Precision Medicine Solutions
The University of Illinois Urbana-Champaign (UIUC) and Infosys, a provider of next-generation digital services and consulting has formed a strategic partnership to develop precision medicine solutions. As part of the strategic partnership, Infosys becomes a member of the Center for Computational Biotechnology and Genomic Medicine (CCBGM). Precision Medicine Strategic Partnership DetailsThe adoption of precision medicine solutions by healthcare companies has significant benefits, including
Read More
FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)
Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More
Pittsburgh Health Data Alliance, Amazon Partner on Machine Learning Research Sponsorship
Pittsburgh Health Data Alliance (PHDA) announced today that it is working closely with Amazon Web Services (AWS), an Amazon.com company, through a machine learning research sponsorship, to advance innovation in areas such as cancer diagnostics, precision medicine, voice-enabled technologies and medical imaging.Leveraging Machine Learning to Power Medical ResearchA unique consortium formed four years ago by UPMC, the University of Pittsburgh and Carnegie Mellon University (CMU), the PHDA uses
Read More
Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative
In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
